Picture
 

Alistair Overeem Blames Anti-Inflammatory Medication for Failed Drug Test

Written by Tom Ngo
April 23rd, 2012
Share on Facebook0Google+0Tweet about this on Twitter

UFC Alistair Overeem

Although Alistair Overeem (Pictured) is scheduled to stand before the Nevada State Athletic Commission on Tuesday to plead his case, the controversial UFC heavyweight decided to reveal his defense to the mixed martial arts world today. According to Overeem, medically prescribed anti-inflammatory medication is what caused him to fail his pre-fight drug test.

“I absolutely do not believe in, nor do I use performance-enhancing drugs,” Overeem expressed in a press release issued by Authentic Sports Management. “I am a clean fighter and I will do whatever it takes to prove this to everyone.

“Prior to the UFC 146 press conference in March, I aggravated an old rib injury on my left side. My doctor prescribed, and I accepted, an anti-inflammatory medication that was mixed with testosterone. I was completely unaware that testosterone was one of the ingredients in the medication. Although I was unaware, I do realize it is my job to know what I am putting into my body.”

Overeem registered a Testosterone/Epitestosterone (T/E) ratio of 14:1 in a random screening late last month. The NSAC allows a T/E ratio of 6:1. Just in case you were wondering, the average male produces approximately a 1:1 ratio.

On April 9th, the UFC filed an application with the NSAC on Overeem’s behalf so he could obtain a license for his UFC 146 title fight against champion Junior dos Santos. The hearing is set for tomorrow at 9AM PT.

However, instead of waiting for the verdict, the UFC decided over the weekend to replace Overeem with Frank Mir because they were steadily approaching pay-per-view deadlines to promote the May 26th show.

In Overeem’s statement, he claims to have been the one that withdrew from the event in order to request a continuance and clear his name with the commission.

Don’t forget to follow @5thRound on Twitter, Facebook and Google+!



COMMENTS